Oncoclínicas calls shareholder assembly to suspend Josephina III fund rights

Oncoclínicas' board accepted Latache's request to convene an extraordinary general assembly to deliberate on suspending the rights of shareholder Josephina III Investment Fund. The move signals a governance dispute between the company and the fund, potentially affecting shareholder dynamics. The outcome is uncertain pending the assembly's decision.